1. Political • Stringent government regulation and powerful purchaser pressures. • Governments focused on pharmaceuticals in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic • European free trade agreements. Social • Ageing populations create pressure on healthcare systems. • Epidemic or chronic diseases (e.g. obesity). Technological • Impact of genetic research on industry. • Utilizing a web of alliances to address multiple customer
Premium Generic drug Pharmaceutical industry Regulation
Introduction Having experienced the SARS‚ July 7th‚ 2005 terrorist attack‚ and the Bird Flu‚ which have slowed down the UK economy and had an adverse effect on the hotel industry‚ there are now clear signs of recovery. This report will first examine the UK hotel market‚ discuss the major industry players and demonstrate the relative importance of key issues. Furthermore‚ it will explore the UK consumer trends‚ present the diversity of backgrounds of investors and provide a future outlook along with
Premium Hotel Motel Boutique hotel
R&D and manufacturing facilities receive ISO 9001 certification from RWTUV‚ Germany 1994 Biocon establishes Syngene International Pvt. Ltd. as a Custom research Company (CRC) to address the growing need for outsourced R&D in the pharmaceutical sector 1996 The commercial success of Biocon’s proprietary fermentation plant leads to a 3-fold expansion Biocon leverages its technology platform to enter biopharmaceuticals and statins 1998 Unilever inks a deal with ICI to sell
Premium Pharmaceutical industry Marketing Pharmacology
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug
Ethics in pharmaceutical marketing xxxxx EMBA 1.1/Academic Skills Subject Outline December 23rd‚ 2012 Prof. xxxxx Ethics and pharmaceutical marketing The pharmaceutical industry has been facing challenges with respect to ethical marketing and promotional practices. The conflict of commercial interests with adherence to ethical practices has been a subject of much deliberation. While such debates tend to have a high degree of subjective and emotive content‚ it is also a concern
Premium Marketing Corporate social responsibility Business ethics
Malijan‚ Mary Erjoy D. GENEROSO PHARMACEUTICALS AND CHEMICALS‚ INC TIME CONTEXT 1978 and in 1988 - GPC engage in the contract manufacturing of pharmaceutical products for both the domestic and export markets and the Generics Bill came in. SUMMARY / ABSTRACT This case examines the management of Mr. David Genereso in the GENERESO PHARMACEUTICALS AND CHEMICALS‚ INC to become a productive and successful company. Mr. David Generoso was a philosophy graduate of a sectarian university in the
Premium Pharmaceutical drug Strategic management Philippines
Table of Contents Table of Contents i Introduction 1 1 Definition of The Pharmaceutical Industry 1 2 Environmental Analysis 2 2.1 Legal Issues 2 2.2 Political Issues 2 2.3 Economic Issues 2 2.4 Social Issues 2 2.5 Technological Issues 2 3 Forces of Competition 3 4 Value Chain 4 4.1 Discovery 4 4.2 Production Development 4 4.3 Manufacturing 4 4.4 Marketing 4 5 Role of Information Systems & Technology 4 6 GlaxoSmithKline 5 7 United Drug 6 7.1 Company Overview
Premium Pharmaceutical industry Pharmacology Drug discovery
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
SMALL SCALE INDIGENOUS PHARMACEUTICAL MANUFACTURING COMPANIES IN NIGERIA TABLE OF CONTENT Title page Certification Dedication Acknowledgement Abstract Table of content CHAPTER ONE 0. INTRODUCTION OF “MARKETING PROBLEMS OF SMALL SCALE INDIGENOUS PHARMACEUTICAL MANUFACTURING COMPANIES IN NIGERIA 1. Background of the Study 2. Statement of the problem 3. Objective of the Study 4. Research Hypothesis 5. Scope of the Study 6. Significance of the Study 7. Definition of
Free E-mail E-mail address Telephone
Strategic Management Topic: The Impact of Strategic Management Decisions – Wilkinson (Case Study) Prepared for Mr. Wiethoff RIHE Prepared by M. M. Khan Business Student -- 2nd year‚ 3rd quarter RIHE 4.03.2013 Wilkinson & its Strategy Businesses must respond to change in order to remain competitive. Developing appropriate strategies‚ which allow progress‚ is essential. Wilkinson was founded in 1930 as Wilkinson Cash Stores by James Kemsey Wilkinson and has remained largely in the
Premium Strategic management Strategic planning Management